Citius Oncology Launches $9 Million Public Offering to Fund LYMPHIR Commercialization Citius Oncology has announced a public offering priced at $9 million to support the commercialization of its oncology therapy LYMPHIR. This article covers the details.

Citius Oncology Launches $9 Million Public Offering to Fund LYMPHIR Commercialization #United_States #CTXR #Cranford #Citius_Oncology #Lympir